ReviewThe Journal of clinical and aesthetic dermatology2025
Aesthetic Treatment Considerations in Patients with Cutaneous Autoimmune Disease.
Review in The Journal of clinical and aesthetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe increasing prevalence of autoimmune disease alongside the growing popularity of cosmetic treatments has placed physicians in a unique position to understand how utilizing such treatments can serve as both beneficial and potentially harmful interventions. The objective of this study was to analyze available literature and identify areas where additional research is needed to guide use of facial aesthetic treatments in patients with cutaneous autoimmune disease.
methodsA literature search was performed on PubMed and Google Scholar for articles describing aesthetic treatments in the setting of autoimmune disease. Additional articles were found through examining the reference sections of resulting articles.
resultsThis analysis revealed numerous gaps in the literature regarding therapeutic use of aesthetic treatments in the management of autoimmune disease. Several case reports and smaller studies suggested positive outcomes with some interventions, however larger-scale studies are needed to create generalizable guidelines for physicians regarding usage of aesthetic treatments as a therapeutic modality. LIMITATIONS: Many studies regarding both efficacy and adverse outcomes of aesthetic treatments excluded patients with cutaneous manifestations of autoimmune disease. Few articles specifically sought to analyze how individual treatments can be used for therapeutic outcomes in this patient population.
conclusionMany cosmetic treatments can serve a therapeutic role in the management of autoimmune conditions with cutaneous manifestations. Treatments such as neurotoxin, filler, light-based devices, autologous platelet-rich plasma, microneedling, and chemical peels may be selectively chosen for use in management of certain autoimmune conditions.
Indexed as
Identifiers
40778011PMC12327559What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.